T he development of mature T cells from thymic precursors is mediated in large part by signals downstream of TCR complexes. The largest population of immature T cells in the thymus are double positive (DP) 3 for the coreceptors CD4 and CD8, have productive TCR ␣-and ␤-chain gene rearrangements, and therefore express a mature TCR signaling complex on their surface. At this stage in development, thymocytes must undergo two concurrent, but distinct, developmental processes to become functional and tolerant mature T cells. One of these processes is known as repertoire selection, which ensures that mature T cells can recognize foreign peptides presented by self-MHC molecules, but will not become activated when they encounter self-peptide/ self-MHC complexes. The second process, lineage commitment, is the process by which thymocytes that recognize peptide in the context of MHC class I become CD8 ϩ cytotoxic T cell precursors, and thymocytes that recognize peptide in the context of MHC class II molecules become CD4
ϩ Th cell precursors. Both these processes are known to be dependent on TCR signaling; however, it has often been debated how the same initial signals can give rise to these different and opposing developmental outcomes.
Current theories propose that the strength of the signal received by a DP thymocyte through its TCR and/or coreceptor can determine the developmental fate of the thymocyte with respect to both selection and lineage commitment. In the case of selection, it is believed that the avidity of the TCR for self-peptide/self-MHC complexes in the thymus will influence the intensity of the TCR signal. Thus, thymocytes that weakly bind self-peptide/self-MHC complexes receive weak signals that induce positive selection and the generation of T cells that would be useful to the individual. In contrast, if the thymocytes bind strongly to self-peptide/self-MHC complexes, a strong signal would be transduced, leading to negative selection and the elimination of potentially autoreactive cells. Consistent with this idea, there is extensive evidence that both TCR avidity for self-peptide/self-MHC and TCR signal strength influence the repertoire selection process (1) . Further, it has recently been demonstrated that there is a clear link between TCR-MHC/peptide avidity and the ensuing strength of the TCR signal (2, 3) .
The events or signals that direct thymocytes into a specific lineage have been more difficult to dissect. Initial studies focused on the CD4 and CD8 coreceptors, including efforts to identify unique signaling molecules/events downstream of each of these coreceptors; however, little progress was made from these approaches. More recent data indicate that alterations in the activities of certain signaling molecules downstream of the coreceptor/TCR may influence lineage commitment. Although still somewhat controversial, it has been shown that both the activity of Lck (4, 5) and the extracellular signal-regulated kinase (Erk)/mitogen-activated protein kinase (MAPK) signaling pathways (6 -8) affect lineage commitment, with high levels of both of these signals leading to CD4 commitment and low levels of these signals leading to CD8 commitment. These studies are consistent with early data indicating that the cytoplasmic tail of CD4 binds more efficiently to Lck that that of CD8 (9 -12) . Putting these observations together, one popular model of lineage commitment suggests that when thymocytes recognize class II MHC/peptide complexes, engaging both the TCR and CD4, stronger Lck signals would be induced compared with engagement of TCR and CD8 during recognition of MHC class I/peptide complexes. In addition, it has been shown that agonist signals through the TCR induce CD4 development, whereas antagonist signals induce CD8 development (13, 14) . Thus, similar to repertoire selection, lineage commitment may also be dependent on the strength of TCR plus coreceptor signaling.
In this study we were interested in determining the role of the Tec family tyrosine kinase, Itk, in both the processes of TCR repertoire selection and lineage commitment. Work from our laboratory and others has suggested that Itk is important for efficient TCR signaling. Studies in peripheral T cells have determined that crosslinking of the TCR in Itk-deficient cells results in reduced PLC-␥ phosphorylation, reduced inositol trisphosphate generation, no sustained Ca 2ϩ flux (15) , and reduced translocation of NFAT into the nucleus (16) . In addition, Itk has been suggested to be important for full activation of the Erk/MAPK signaling pathway (17) . From these studies it appears that although Itk is not required for the activation of these signaling pathways, in its absence, signals downstream of the TCR are reduced. Therefore, it seemed likely that both selection and lineage commitment would be altered in the absence of Itk.
The analysis of itk Ϫ/Ϫ mice crossed to either a class I-or a class II-restricted TCR transgenic line revealed that virtually no TCR transgenic T cells developed in the absence of Itk (18) . Based on this original observation and recent studies with these same TCR transgenics crossed to both itk Ϫ/Ϫ and rlk Ϫ/Ϫ itk Ϫ/Ϫ mice, which lack an additional Tec family member, it has been proposed that Tec family kinases play a role in setting thresholds for thymocyte development (19) . To better understand the role of Tec family members in thymocyte development, we crossed itk Ϫ/Ϫ mice to additional TCR transgenic lines that express TCRs with different avidities for their selecting ligands in the thymus. These mice would allow us to determine whether the requirement for Tec family signals is influenced by the avidity of the TCR on the developing thymocyte. In addition, these mice provide the opportunity to determine whether signaling thresholds for both selection and lineage commitment are shifted in the absence of Itk.
Materials and Methods

Mice
Itk-deficient mice were generated in our laboratory previously (15) . These mice were crossed to 2B4 (20) , 5C.C7 (21) , and AND (22) TCR transgenic mice, all of which were on the B10.BR (H-2 k ) genetic background. The itk Ϫ/Ϫ mice crossed to the TCR transgenic mice had a mixed 129/B10 genetic background (H-2 b ). Since the 129 strain carries two superantigens that delete V␤3-expressing T cells, a PCR screen was designed to distinguish mice that carried at least one SAg from those that were SAg negative; SAg-negative mice were used for all experiments. The nontransgenic itk ϩ/Ϫ and itk Ϫ/Ϫ mice in all figures were backcrossed to B10 mice at least eight times. Mice were analyzed between 6 and 12 wk of age, and all TCR transgenic control mice are itk ϩ/Ϫ littermates. Neonates were analyzed 22-40 h postbirth. When examined, there were no significant phenotypic differences in the lymphocyte profiles of TCR transgenic itk ϩ/Ϫ and itk ϩ/ϩ mice (data not shown). Mice were bred and maintained in a specific pathogen-free facility.
Antibodies
The following mAbs, purchased from BD Pharmingen (San Diego, CA), were used for staining cells: anti-CD4-PE (H129.19), anti-CD4-CyChrome (anti-CD4-Cy; H129.19), anti-CD8␣-FITC (53-6.7), anti-CD8␣-Cy (53-6.7), anti-CD8␣-allophycocyanin (53-6.7), anti-TCR␣␤-Cy (H57-597), anti-V␤3-PE (KJ25), anti-V␣11.1, 11.2
-FITC (RR8.1), anti-CD5-Cy (53-7.3), anti-CD69-bio (H1.2F3), anti-CD24 (heat-stable Ag (HSA))-bio (M1/69), purified hamster anti-mouse Bcl-2 (3F11), and purified hamster anti-trinitrophenol (107.3). Hamster Abs were detected by goat F(abЈ) 2 anti-hamster IgG (HϩL)-FITC (Caltag Laboratories, Burlingame, CA). In most cases the 2B4 TCR transgenic was detected by staining with the A2B4-2 Ab (23), which was purified and conjugated to FITC in our laboratory. Biotinylated Abs were detected using strepavidin-allophycocyanin (BD Pharmingen).
Cell preparation, staining, and flow cytometry
Lymphocyte cell suspensions were made from thymus, spleen, and lymph nodes (LNs; pooled inguinal, axillary, brachial, and cervical) by dissociation between two frosted slides in RPMI and 10% FCS. RBC were lysed by incubation in Tris-ammonium chloride for 5 min at room temperature. Cells were washed, resuspended in FACS buffer (1ϫ HBSS, 2% FCS, and 0.01% NaN 3 
Results
T cell development is altered in Itk-deficient mice
The examination of itk Ϫ/Ϫ mice generated in our laboratory (15) suggested that Itk plays a role in T cell development. As previously reported (18, 19) , we observed altered CD4 ϩ and CD8 ϩ T cell populations in the thymus, spleen, and LN of itk Ϫ/Ϫ mice ( Fig. 1 ). Although we did not observe significant differences in lymphocyte cellularity in these organs, the proportions of CD4 ϩ and CD8 ϩ T cells differ from those in control mice (itk ϩ/ϩ or itk ϩ/Ϫ ). In the thymus, itk Ϫ/Ϫ mice have a slight reduction in the percentage of CD4 ϩ CD8 Ϫ (SP) cells and at least a 2-fold increase in the percentage of CD8 ϩ SP cells (Fig. 1A) . However, in the periphery the percentage of CD4 ϩ cells is, on the average, half that in control mice, while the percentage of CD8 ϩ T cells is essentially normal (Fig. 1B) .
Based on this phenotype we hypothesized that the development of CD4 ϩ T cells is more affected by the absence of Itk. In addition, we were intrigued by the observation that there was a consistent increase in both the percentage and number of CD8 ϩ T cells in the thymus of itk Ϫ/Ϫ mice. One potential explanation for this phenotype is that CD4/CD8 lineage commitment is altered in the absence of Itk, leading to the development of MHC class II-restricted DP thymocytes into CD8 ϩ SP cells. To better understand the defects in itk Ϫ/Ϫ mice and the role of Itk during selection and lineage commitment, we crossed itk Ϫ/Ϫ mice to several lines of TCR transgenic mice.
Development of T cells expressing 2B4, 5C.C7, or AND TCR in H-2 k mice is affected by the absence of Itk
We crossed itk Ϫ/Ϫ mice to three different lines of TCR transgenics, specifically, 2B4 (20) , 5C.C7 (21) , and AND (22) transgenic mice. Each of these transgenics expresses a TCR that uses V␣11 and V␤3 gene segments and is specific for a moth cytochrome c peptide (88 -103) bound to the MHC class II molecule I-E k . However, each TCR is thought to have a different avidity for selecting ligand(s) in the thymus based on differences in the efficiency of positive selection (2B4 Ͻ 5C.C7 Ͻ AND) (24) . Thus, the use of these TCR transgenic lines would allow us to determine whether the absence of Itk would differentially affect the development of cells bearing TCRs presumed to have varying avidities for selecting ligands. We chose to use class II-restricted TCR transgenics because the development of CD4 ϩ T cells seemed to be more affected by the absence of Itk. In addition, it has been proposed that signaling strength may be a potential mechanism for T cell lineage commitment (25) and that CD8 ϩ T cells develop as a result of weaker signals. Thus, we were interested in determining whether the absence of Itk would lead to lineage switching in one or more of these TCR transgenic lines. This outcome would be visible as the development of MHC class II-restricted itk Ϫ/Ϫ thymocytes into CD8 ϩ T cells instead of CD4 ϩ T cells, due to reduced signaling in the absence of Itk.
Analysis of the 2B4, 5C.C7, and AND H-2 k itk Ϫ/Ϫ mice revealed that the ability of the different TCR transgenic thymocytes to develop and populate the periphery in the absence of Itk varies in a manner consistent with the proposed avidity of each TCR for its selecting ligand(s) in the thymus. In the 2B4 and 5C.C7 transgenic itk Ϫ/Ϫ mice, the percentages and absolute numbers of CD4 ϩ SP cells in the thymus are dramatically reduced compared with the corresponding itk ϩ/Ϫ TCR transgenic ( Fig. 1A and Table I ). In the AND itk Ϫ/Ϫ mice, the average percentage of CD4 ϩ SP cells in the thymus is reduced. However, as a reflection of the slight increase in thymic cellularity in AND itk Ϫ/Ϫ mice, the absolute numbers of CD4 ϩ SP cells are comparable to that seen in AND itk ϩ/Ϫ mice ( Table I) . The hierarchy of developmental defects seen in the thymus is also reflected in the peripheral T cell populations in all three TCR transgenic lines (Fig. 1B) , and correlates with the presumed avidity 
a The percentage and absolute numbers of T cell subsets in the thymus and lymph nodes are given. The values are the mean of 3-10 animals for each genotype with SEMs. Absolute numbers are given in millions. Similar analyses were performed on splenocytes with comparable results (data not shown).
of each TCR for selecting ligands. In itk Ϫ/Ϫ mice that express the 2B4 TCR, which is thought to be a low avidity TCR, there are very few CD4 ϩ cells that express the transgenic TCR. In contrast, there are many more TCR transgenic CD4 ϩ T cells in the itk Ϫ/Ϫ mice that express a high avidity TCR, such as 5C.C7 or AND. In fact, in the AND itk Ϫ/Ϫ mice, the percentage and absolute number of these cells are comparable to those in wild-type AND mice.
It is important to note that the mice represented in Fig. 1 are all ϳ8 wk of age. In mice that are younger (ϳ4 wk), the differences in the percentage of peripheral CD4 ϩ transgenic T cells between itk Ϫ/Ϫ mice and wild-type controls are more substantial in all three transgenic lines. This is indicative of the lower percentages of CD4 ϩ SP being generated in the thymus of these mice. As these mice age, the numbers of peripheral CD4 ϩ transgenic T cells in AND itk Ϫ/Ϫ mice increase to numbers equivalent to those found in itk ϩ/Ϫ mice; however, this is not the case for the 2B4 and 5C.C7 itk Ϫ/Ϫ mice. These observations suggest that age is not the only factor that allows the AND itk Ϫ/Ϫ mice to accumulate as many CD4 ϩ transgenic T cells as wild-type AND mice (see below).
Development of AND itk Ϫ/Ϫ T cells is affected by the strength and density of selecting ligands expressed by APC in the thymus
Based on the analysis of 2B4, 5C.C7, and AND itk Ϫ/Ϫ mice, it appears that the presumed avidity of the TCR for its selecting ligand(s) in the thymus plays an important role in the development of T cells in the absence of Itk. However, it is known that the development of T cells in each TCR transgenic line can be somewhat idiosyncratic, due in part to the fact that transgene expression can affect development before thymocytes reach the DP stage (26) . Therefore, it is possible that the developmental efficiency of thymocytes in each of the transgenics is not solely based on their given avidities for the selecting ligands. To address this concern, we chose to analyze itk Ϫ/Ϫ mice that express one of the transgenic TCRs on different MHC backgrounds in which varying levels of two different selecting ligands are expressed.
The AND TCR can be positively selected on both I-E k and I-A b molecules (27) . However, the generation of mature CD4 Table I ). A probable explanation for this phenotype is that, as previously suggested (27) , the interaction between AND thymocytes and their selecting ligand(s) in the thymus of AND k/k mice is of such high avidity that some of the cells are actually deleted in these mice. This is supported by the fact that AND (Table I ). The phenotype of AND b/b itk Ϫ/Ϫ mice has been reported previously (18, 19) , and our analysis is in agreement with these reports. Specifically, the development of transgenic T cells in these mice is dramatically reduced compared with that in AND b/b itk ϩ/Ϫ mice. Despite the significant numbers of CD4 ϩ SP cells in both the thymus and LNs of the AND b/b itk Ϫ/Ϫ mice (Fig. 2 ), very few of the CD4 ϩ cells in the periphery express high levels of the transgenic TCR, as demonstrated by staining for V␣11 (Fig. 2B) . In contrast, AND itk Ϫ/Ϫ mice that express I-E k molecules have significant numbers of CD4 ϩ V␣11 ϩ T cells in both the thymus and periphery. As shown in the previous section, the generation of transgenic T cells in the thymus of AND k/k itk Ϫ/Ϫ mice appears to be slightly less efficient than in AND k/k itk ϩ/Ϫ mice, but the percentage and number of peripheral transgenic T cells are comparable. Although time may lead to the accumulation of transgenic T cells in the itk Ϫ/Ϫ mice, it is also likely that the AND k/k itk Ϫ/Ϫ mice develop as many peripheral cells as wild-type AND mice, because the deletion of some of the AND thymocytes that takes place in wild-type AND k/k mice does not occur, or occurs to a lesser extent, in the absence of Itk. Wild-type AND k/b mice have the highest number of CD4 ϩ SP T cells in the thymus of all three backgrounds examined, presumably because they express the strongly selecting I-E k molecules on thymic stromal cells, but due to the lower density of this selecting molecule, the partial deletion that occurs in AND k/k mice is absent. The percentage of CD4 ϩ V␣11 high T cells in both the thymus and lymph nodes of AND k/b itk Ϫ/Ϫ mice is one-half to one-third the number of these cells found in AND k/b itk ϩ/Ϫ mice ( Fig. 2 and Table I) ϩ TCR transgenic cells in both the thymus and periphery of these mice is impaired by the absence of Itk. We hypothesized that this lack of accumulation is due to a defect in the generation or positive selection of these cells. However, it remained possible that mature CD4 ϩ cells were being generated normally, but their survival was impaired in the absence
It has been shown that Bcl-2 is up-regulated in a subset of TCR high DP thymocytes and remains high in SP cells (28) . This expression pattern correlates with cells that have received or are receiving positive selection signals. Fig. 3 depicts intracellular staining for Bcl-2 in itk Ϫ/Ϫ thymocytes compared with their wildtype littermates. In non-TCR transgenic itk Ϫ/Ϫ cells, the levels of Bcl-2 are up-regulated in both the DP TCR high and CD4 ϩ SP populations to the same extent as in thymocytes from a wild-type littermate (Fig. 3A) . The same is true in the analogous populations of TCR transgenic thymocytes on all the selecting backgrounds ( Fig. 3B and data not shown) . These data indicate that itk Ϫ/Ϫ cells in which the early stages of positive selection are properly initiated, as determined by up-regulation of TCR, also properly upregulate the survival factor Bcl-2. However, within the entire DP population from AND k/b itk Ϫ/Ϫ thymi, a greater proportion of DP cells have background (very low) levels of Bcl-2. This is probably due to fewer cells in these mice receiving the initial signals for selection.
Analysis of the Bcl-2 levels in cells undergoing selection and in cells that have completed selection suggested that itk Ϫ/Ϫ thymocytes properly up-regulated this important survival factor and thus would have comparable viability as their wild-type counterparts. Therefore, we were interested in determining whether the regulation of additional markers is normal in itk Ϫ/Ϫ thymocytes undergoing selection; this analysis would allow us to identify the stage(s) of selection in which itk Ϫ/Ϫ thymocytes are defective. This analysis revealed that a smaller percentage of DPs have up-regulated TCR in the absence of Itk in all TCR transgenic lines (data not shown), suggesting that fewer itk Ϫ/Ϫ DP cells are receiving a strong enough signal to initiate selection. Next we wanted to determine whether Itk-deficient thymocytes would also be impaired at later stages of positive selection. Thus, we examined the pattern of CD69 expression on TCR high DP and SP thymocytes (Fig. 4B) Fig. 4B , this is, in fact, the case, suggesting that in the absence of Itk, thymocytes do not progress through these stages as efficiently as cells that express Itk. Finally, we examined HSA levels on the CD4 ϩ SP cells from these mice (Fig. 4C) . HSA is down-regulated in the final stage of thymocyte selection and differentiation, such that the most mature cells are HSA Ϫ (30) . Although more of the CD4 ϩ SP thymocytes in AND itk Ϫ/Ϫ mice are still CD69 high compared with those in control mice, it appears that the same proportion of the CD4 ϩ SPs have begun to down-regulate HSA in both itk ϩ/Ϫ and itk Ϫ/Ϫ mice. This suggests that the down-regulation of HSA can take place while TCR signaling is still occurring and that this happens normally even in the absence of Itk. T cells (15) and thymocytes (32) indicated that T cells get a weaker signal through their TCR in the absence of Itk; thus, we would expect that CD5 levels would be lower on thymocytes from itk Ϫ/Ϫ mice. This prediction was first verified by staining thymocytes from non-TCR transgenic itk Ϫ/Ϫ mice, which revealed that DP thymocytes have significantly lower levels of CD5 compared with DPs from itk ϩ/Ϫ mice (Fig. 5A ). We also examined CD5 levels on DP and CD4 ϩ SP cells from all the TCR transgenic mice to compare T cells that all express the same TCR (Fig. 5B) . Similar to the non-TCR transgenic mice, all the transgenic mice lacking Itk had lower surface levels of CD5 on their DP thymocytes with the exception of AND k/k itk Ϫ/Ϫ mice. Comparison of AND k/k , AND k/b , and AND b/b mice shows that as the strength of the selecting background increases, the differences in CD5 surface expression between DPs that express Itk and those that do not is diminished. Interestingly, the CD5 surface levels do not seem to vary significantly among the wild-type AND mice with different selecting backgrounds. Unlike the non-TCR transgenic itk Ϫ/Ϫ mice, all the TCR transgenic itk Ϫ/Ϫ mice have lower levels of CD5 on their CD4
The expression of CD5, a marker for TCR signal strength, is lower on thymocytes from itk
ϩ SP thymocytes, further indicating that the strength of the signal through the same TCR is lower in cells that lack Itk. Staining with the anti-V␣11 Ab confirms that the differences in CD5 expression are not due to lower TCR levels on itk Ϫ/Ϫ thymocytes (Fig. 5B) .
Lineage commitment is not affected by reduced TCR signaling in the absence of Itk
In light of increasing evidence that the strength of the TCR signal influences CD4/CD8 lineage commitment, and the suggestion that Tec family kinases are important for regulating TCR signaling thresholds (19), we were interested in determining whether lineage commitment would be affected in itk Ϫ/Ϫ mice. This model of lineage commitment proposes that strong signals downstream of the TCR induce DPs to differentiate into CD4 ϩ T cells, while weak signals downstream of the TCR cause DPs to differentiate into CD8 ϩ T cells (25) . The TCR transgenic itk Ϫ/Ϫ mice that we generated to examine the role of Itk in positive selection also provided us with an ideal system to examine how lineage commitment would be affected in the absence of Itk, as these mice represent a range of TCR avidities for selecting ligands. Specifically, we anticipated that lineage switching might occur in some of the TCR transgenics, particularly those with low selection efficiencies. In such an instance, the loss of transgenic CD4 ϩ SP cells would be compensated for by an increase in transgenic CD8 ϩ SP cells. This expectation would be consistent with the increased percentage of CD8 ϩ SP cells seen in non-TCR transgenic itk Ϫ/Ϫ mice. As shown in Figs. 1 and 2 there were a small number of CD8 ϩ SP cells in the thymus and LN of all TCR transgenic mice. The percentage and absolute number of these cells that express high levels of the transgenic TCR are shown in Table I . In virtually all cases there was no significant increase in the absolute number of transgenic TCR high CD8 ϩ SPs in the absence of Itk as determined by Student's t test ( p Ͻ 0.05). The only exception was in the LN of AND b/b mice, in which the number of CD8 ϩ cells was slightly increased. Therefore, the data from the TCR transgenic mice suggest that although the selection of CD4 ϩ T cells is reduced, lineage commitment occurs normally.
If this is indeed the case, the issue of why non-TCR transgenic itk Ϫ/Ϫ mice have such a large number of CD8 ϩ SP cells in the thymus and an altered CD4:CD8 ratio in the periphery remained unresolved. To address this question we analyzed the expression of multiple thymocyte and T cell markers on the CD8 ϩ SP cells in itk Ϫ/Ϫ mice (Fig. 6A) . The phenotype that we observe is that the majority of the CD8 ϩ cells in the thymus of itk Ϫ/Ϫ mice appeared to be mature CD8 ϩ T cells rather than newly developed CD8 ϩ SP cells. For instance, the vast majority of CD8 ϩ SP thymocytes in itk Ϫ/Ϫ mice are HSA low/Ϫ , and thus resemble peripheral T cells rather than maturing thymocytes (Fig. 6A) . Likewise, the analysis of Bcl-2 (Figs. 3A and 6 ) and CD5 (Figs. 5A and 6A ) expression on the CD8 ϩ SPs of itk Ϫ/Ϫ mice demonstrates that the majority of these cells have high levels of both of these proteins, similar to the levels found on the most mature thymocytes or peripheral T cells.
Although the analysis of these markers suggests that a significant number of CD8 ϩ SPs in the thymus of itk Ϫ/Ϫ mice have a mature phenotype, we are unable to determine whether these cells are peripheral cells that have returned to the thymus or cells that have fully matured, but are not exported from the thymus normally. It has been shown that activated peripheral T cells can reenter the thymus (33) , so we decided to analyze the expression of activation markers on these CD8
ϩ SPs. The analysis of CD69, which is expressed on activated T cells, revealed that there was no difference in the proportion of CD8 ϩ SPs that were CD69 ϩ between wild-type and itk Ϫ/Ϫ mice. We also examined the activation/memory marker CD44. The expression of CD44 is up-regulated on cells as they become activated, but, unlike CD69, it remains high, and thus is often used as a marker for memory T cells (34) . As shown in Fig. 6A , the majority of CD8
ϩ SP thymocytes in itk Ϫ/Ϫ mice are CD44 high , while in wild-type mice the majority of these cells are CD44
low . Based on these results it appears that the CD8 ϩ SP thymocytes in itk Ϫ/Ϫ mice are not activated, but may have been previously. These data leave open the possibility that activated CD8 ϩ cells recirculate from the periphery to the thymus in itk Ϫ/Ϫ mice, but in a steady-state analysis show up largely as previously activated cells. Alternatively, it is possible that the CD8 ϩ SP cells acquire this phenotype in the thymus due to irregular development. Fig. 6A while still in the thymus, it must occur postnatally during later waves of CD8 ϩ T cell maturation.
Discussion
The analysis of mice that are deficient in various TCR signaling molecules has provided significant insight into the role of these molecules in T cell development. In this study we use Itk-deficient mice crossed to several TCR transgenic lines to determine how altering the level of TCR signaling affects the processes of positive selection and CD4/CD8 lineage commitment. Biochemical studies with Itk-deficient thymocytes and T cells indicate that this kinase is important for efficient PLC-␥1 activation leading to sustained Ca 2ϩ mobilization and Erk/MAPK activation in response to TCR stimulation (15, 19) . Although these pathways are reduced by the absence of Itk, signaling is not completely abolished, possibly due to weak compensation by other Tec family kinases, such as Rlk/ Txk (19) . Thus, itk Ϫ/Ϫ mice provide an ideal opportunity to determine how decreased activation of these signaling pathways affects T cell development.
For our studies we crossed itk Ϫ/Ϫ mice to three lines of MHC class II-specific TCR transgenics on three different MHC backgrounds. A previous study has addressed the role of Tec kinases in setting the signaling threshold between positive and negative selection using a single MHC class I TCR transgenic system. Here we address the effect of decreased TCR signaling on positive selection over a range of TCR avidities as well as on CD4 vs CD8 lineage commitment. Our results, based on analyses of thymocytes, show that the efficiency of positive selection is reduced in all cases in the absence of Itk. Interestingly, we did not observe some TCR/MHC combinations in which positive selection was completely abolished and others that were unaffected by the absence of Itk.
These studies extend previous reports of thymic selection in Itk-deficient mice by substantiating the conclusion that reduced CD4 ϩ T cell numbers result from defective positive selection, as opposed to reduced CD4 ϩ cell survival. First, we demonstrated that the survival factor, Bcl-2, is up-regulated to an equivalent degree in DP thymocytes, SP thymocytes, and peripheral T cells from itk Ϫ/Ϫ mice compared with control mice. In addition, the expression of other surface markers that define the final stage of thymocyte maturation, such as HSA, CD69, CD44, and CD62 ligand, is similar on cells generated in wild-type vs itk Ϫ/Ϫ TCR transgenic mice. In the course of this analysis we also observed that wild-type AND TCR transgenic mice expressing the highly selecting ligand, IE k , had fewer thymocytes with high levels of CD69. Thus, in an environment where thymocytes are receiving strong selection signals, there are fewer cells in the CD69 high transition stage, and there is an increase in the more mature CD69 Ϫ
CD4
ϩ SP subset. In the Itk-deficient AND mice there is a decrease in the overall number of TCR high thymocytes; however, among those cells, there is a dramatic increase in the proportion of CD69 high transition cells. This suggests that thymocytes receiving weaker signals during positive selection may require longer to complete the selection process. Together, these findings support the conclusion that in the absence of Itk, fewer thymocytes undergo positive selection, and those that do take longer to become fully mature CD4 ϩ SP cells. Overall, these data reinforce the view of positive selection as an inherently stochastic process, where only a fraction of thymocytes with appropriate TCRs receive sufficient signals to undergo selection before they succumb to programmed cell death (death by neglect). Positive selection is thought to take 1.5-2 days of continuous low level signaling through the TCR (35) , and it has been proposed that there are a limiting number of niches that are present in the thymus that will support selection (36) . This concept has been used to explain why, in TCR transgenic mice in which all developing thymocytes express an appropriate TCR, the majority of cells do not actually get selected. Thus, one explanation for the less efficient development of itk Ϫ/Ϫ thymocytes is that these cells take longer to receive sufficient signals, and due to the limiting niches, fewer cells are successfully selected before undergoing cell death. This probabilistic model of positive selection is also consistent with the outcomes we observed in itk Ϫ/Ϫ mice with a range of avidities of TCR-MHC interactions (e.g., AND b/b vs AND k/b or AND k/k ), where the higher the TCR avidity, the higher the probability that even cells lacking Itk will achieve sufficient signals to promote maturation and survival.
Signals downstream of TCR complexes on thymocytes are also important for developmental processes in addition to positive selection. At the pro-to pre-T cell transition, signals downstream of the pre-TCR are required for proliferation, survival, differentiation, and allelic exclusion. Recent evidence suggests an important role for PLC-␥ in pre-TCR signaling (37) . This observation suggests a role for Itk in this signaling pathway, as Itk is important for full activation of PLC-␥1 in peripheral T cells (15) . In fact, we did observe an increase in the percentage of CD4 Ϫ CD8 Ϫ thymocytes in a number of the TCR-transgenic itk Ϫ/Ϫ mice (Figs. 1A and 2A ). However, initial characterization of the CD4 Ϫ CD8 Ϫ CD3 Ϫ (TN) thymocyte populations in non-TCR transgenic Itk-deficient mice indicates that there is no overt defect at this stage of development, as determined by CD25 and CD44 analysis (J. Lucas and L. Berg, unpublished observations). Therefore, we believe the increase in TN thymocytes is more reflective of a loss of DP and/or CD4 ϩ SPs in these mice. Consistent with this is the fact that a significant increase in the percentage of TN cells is only observed in itk Ϫ/Ϫ TCR transgenic mice that have an overall reduction in thymic cellularity.
This study also demonstrated that the majority of CD8 ϩ thymocytes in itk Ϫ/Ϫ mice have a phenotype that is not consistent with newly generated CD8 ϩ SPs, but instead resembles peripheral T cells with a memory phenotype (CD44 high ). Corroborating this observation, we found that the majority of CD8 ϩ T cells in the periphery of itk Ϫ/Ϫ mice are also CD44 high (data not shown). One interpretation of these data is that the CD44 high CD8 ϩ SP thymocytes in itk Ϫ/Ϫ mice are previously activated peripheral cells that have reentered the thymus. An alternative possibility is that these cells could be the products of homeostatic expansion, although this seems unlikely, as itk Ϫ/Ϫ mice are not lymphopenic. A third possibility is that the CD8 ϩ SP thymocytes acquire this mature phenotype in the thymus and accumulate there before being exported to the periphery. We have begun to address this by looking at the phenotype of the CD8 ϩ SPs in neonatal mice. The examination of the very earliest CD8
ϩ SPs suggest that they do not acquire the mature phenotype early in development. A more detailed kinetic analysis of CD8 ϩ SP maturation and thymocyte emigration is ongoing and should help shed light on the nature of these cells. However, at this point we believe that our initial hypothesis that CD4 development is more affected by the absence of Itk may need revision, as the defects in CD8 ϩ T cell development may have been masked by expansion (in the thymus and/or the periphery) of the few cells that are selected.
The most unexpected result that we observed is the lack of effect on CD4/CD8 lineage commitment in Itk-deficient mice. The initial analyses of non-TCR transgenic itk Ϫ/Ϫ mice revealed that T cells of both lineages develop, but that the normal ratio of CD4 ϩ to CD8 ϩ cells is altered in favor of increased CD8 ϩ cells. An attractive hypothesis to explain this observation was that stronger selection signals induce CD4 ϩ differentiation, and that in the absence of Itk, class II-specific thymocytes would develop into CD8 ϩ T cells due to weaker selection signals. This potential explanation for the phenotype of itk Ϫ/Ϫ mice was strengthened by recent studies identifying signaling molecules that appear to influence CD4/CD8 lineage decisions in the thymus. For instance, the level of Lck activity in developing thymocytes has been shown to directly affect the outcome of lineage commitment (4). As Itk is directly downstream of Lck, alterations in Lck activity should be reflected in concomitant changes in Itk activity. More importantly, the activity of the Erk/MAPK signaling pathway has also been shown to influence CD4/CD8 lineage commitment and as stated above, itk Ϫ/Ϫ T cells have reduced phosphorylation of Erk1/2 following CD3 cross-linking (19) . Therefore, because molecules that are thought to be both upstream and downstream of Itk signaling are implicated in CD4/CD8 lineage commitment, it seemed likely that Itk would also be involved in this process.
Nonetheless, our data argue that Itk is not involved in CD4/CD8 lineage commitment. In non-TCR transgenic itk Ϫ/Ϫ mice the bulk of CD8
ϩ SP thymocytes present do not represent newly differentiating cells. Furthermore, in all five different TCR transgenic/ MHC backgrounds that we examined we never observed a substantial increase in the number of CD8 ϩ cells developing in the absence of Itk. It is possible that we did not see a difference because the alteration in the strength of the TCR signal in these cases was either too large or too small without Itk, such that development of the transgenic T cells was nearly abolished (too large) or was reduced, but not enough to influence lineage commitment (too small). However, with the number of combinations examined, we do not think that this explanation is likely. Rather, we believe that the activity of Itk is not required for the signal that induces commitment to either specific lineage.
These observations support the interesting possibility that unique signals downstream of the coreceptor are responsible for lineage commitment and that Itk is not involved in this signaling pathway. Consistent with this idea, previous studies have shown that altering the coreceptor, Lck activity, or Erk/MAPK signaling can have an effect on lineage commitment, but that simply reducing TCR signaling does not (25) . An alternative view of lineage commitment has proposed that CD4/CD8 lineage decisions are influenced by the kinetics/duration of TCR/coreceptor signaling (38, 39) , rather than the strength, with CD4 lineage commitment requiring sustained TCR signals. Thus, it is possible that we did not observe lineage switching in the class II-restricted TCR transgenic itk Ϫ/Ϫ mice because these thymocytes may have received sustained signals for a sufficient period of time to ensure proper differentiation. Finally, it will be interesting to determine how development of the CD8 lineage is altered in thymocytes that lack Itk. Although we did not observe lineage switching, the CD8 ϩ SPs in itk Ϫ/Ϫ mice have an unusual phenotype, which may suggest some alteration in the maturation of these cells. Therefore, we are currently crossing itk Ϫ/Ϫ mice to class I-restricted TCR transgenic mice to further examine this issue.
